InvestorsHub Logo
Followers 31
Posts 1587
Boards Moderated 0
Alias Born 01/27/2011

Re: SmurfVA post# 1894

Tuesday, 08/27/2013 9:19:00 AM

Tuesday, August 27, 2013 9:19:00 AM

Post# of 4126
I love this line:

"We are very pleased to have received Breakthrough Therapy Designation for Firdapse™ and we are excited by the FDA's decision to place our product in a category that may enable expedited development and review for patients with LEMS," said Patrick McEnany, President and Chief Executive Officer of Catalyst. "With no approved or effective symptomatic treatment currently available for LEMS, Firdapse™ has the potential to be the first-line treatment option for patients with this rare condition."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CPRX News